Allogene Therapeutics Stock Price History
| ALLO Stock | USD 2.28 0.07 3.17% |
Below is the normalized historical share price chart for Allogene Therapeutics extending back to October 11, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Allogene Therapeutics stands at 2.28, as last reported on the 26th of November, with the highest price reaching 2.36 and the lowest price hitting 2.23 during the day.
If you're considering investing in Allogene Stock, it is important to understand the factors that can impact its price. Allogene Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0109, which signifies that the company had a -0.0109% return per unit of risk over the last 3 months. Allogene Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Allogene Therapeutics' Mean Deviation of 4.26, insignificant risk adjusted performance, and Standard Deviation of 5.23 to double-check the risk estimate we provide.
At this time, Allogene Therapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 26th of November 2024, Liabilities And Stockholders Equity is likely to grow to about 695.7 M, while Common Stock Total Equity is likely to drop about 121.7 K. . At this time, Allogene Therapeutics' Price To Sales Ratio is very stable compared to the past year. As of the 26th of November 2024, Price Book Value Ratio is likely to grow to 1.03, while Price Earnings Ratio is likely to drop (1.62). Allogene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of October 2018 | 200 Day MA 3.1097 | 50 Day MA 2.6866 | Beta 0.836 |
Allogene |
Sharpe Ratio = -0.0109
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALLO |
Estimated Market Risk
| 5.18 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Allogene Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Allogene Therapeutics by adding Allogene Therapeutics to a well-diversified portfolio.
Price Book 1.0308 | Enterprise Value Ebitda (1.04) | Price Sales 11.1 K | Shares Float 151.9 M | Wall Street Target Price 9.0417 |
Allogene Therapeutics Stock Price History Chart
There are several ways to analyze Allogene Stock price data. The simplest method is using a basic Allogene candlestick price chart, which shows Allogene Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 6, 2024 | 3.22 |
| Lowest Price | November 20, 2024 | 2.05 |
Allogene Therapeutics November 26, 2024 Stock Price Synopsis
Various analyses of Allogene Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Allogene Stock. It can be used to describe the percentage change in the price of Allogene Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Allogene Stock.| Allogene Therapeutics Price Rate Of Daily Change | 1.03 | |
| Allogene Therapeutics Price Daily Balance Of Power | 0.54 | |
| Allogene Therapeutics Price Action Indicator | 0.02 |
Allogene Therapeutics November 26, 2024 Stock Price Analysis
Allogene Stock Price History Data
The price series of Allogene Therapeutics for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 1.17 with a coefficient of variation of 9.12. The prices are distributed with arithmetic mean of 2.67. The median price for the last 90 days is 2.68.| Open | High | Low | Close | Volume | ||
11/26/2024 | 2.26 | 2.36 | 2.23 | 2.28 | ||
| 11/25/2024 | 2.26 | 2.36 | 2.23 | 2.28 | 3,957,489 | |
| 11/22/2024 | 2.12 | 2.23 | 2.09 | 2.21 | 1,433,020 | |
| 11/21/2024 | 2.06 | 2.14 | 2.01 | 2.11 | 1,895,528 | |
| 11/20/2024 | 2.11 | 2.14 | 1.99 | 2.05 | 2,447,289 | |
| 11/19/2024 | 2.13 | 2.14 | 2.04 | 2.12 | 2,813,412 | |
| 11/18/2024 | 2.30 | 2.32 | 2.14 | 2.15 | 2,917,320 | |
| 11/15/2024 | 2.52 | 2.52 | 2.26 | 2.27 | 3,090,897 | |
| 11/14/2024 | 2.72 | 2.75 | 2.46 | 2.46 | 2,623,078 | |
| 11/13/2024 | 2.86 | 2.95 | 2.71 | 2.72 | 1,811,231 | |
| 11/12/2024 | 3.01 | 3.05 | 2.83 | 2.84 | 2,274,542 | |
| 11/11/2024 | 3.05 | 3.17 | 2.99 | 3.09 | 2,902,633 | |
| 11/08/2024 | 3.24 | 3.26 | 2.95 | 3.08 | 2,839,289 | |
| 11/07/2024 | 3.26 | 3.36 | 3.17 | 3.19 | 2,515,976 | |
| 11/06/2024 | 3.05 | 3.29 | 2.99 | 3.22 | 4,034,052 | |
| 11/05/2024 | 2.96 | 3.04 | 2.88 | 2.99 | 2,599,163 | |
| 11/04/2024 | 2.73 | 3.03 | 2.66 | 3.00 | 3,164,972 | |
| 11/01/2024 | 2.57 | 2.83 | 2.57 | 2.72 | 2,534,770 | |
| 10/31/2024 | 2.64 | 2.73 | 2.54 | 2.56 | 2,208,055 | |
| 10/30/2024 | 2.74 | 3.01 | 2.64 | 2.64 | 2,056,238 | |
| 10/29/2024 | 2.68 | 3.01 | 2.67 | 2.80 | 3,285,326 | |
| 10/28/2024 | 2.48 | 2.75 | 2.45 | 2.68 | 3,088,201 | |
| 10/25/2024 | 2.56 | 2.58 | 2.44 | 2.44 | 2,087,305 | |
| 10/24/2024 | 2.77 | 2.78 | 2.54 | 2.54 | 2,052,414 | |
| 10/23/2024 | 2.80 | 2.85 | 2.70 | 2.77 | 3,304,784 | |
| 10/22/2024 | 2.76 | 2.83 | 2.68 | 2.80 | 1,117,123 | |
| 10/21/2024 | 2.82 | 2.90 | 2.78 | 2.80 | 1,567,712 | |
| 10/18/2024 | 2.72 | 2.86 | 2.71 | 2.84 | 1,095,378 | |
| 10/17/2024 | 2.82 | 2.85 | 2.68 | 2.69 | 842,915 | |
| 10/16/2024 | 2.71 | 2.87 | 2.69 | 2.85 | 1,306,147 | |
| 10/15/2024 | 2.62 | 2.73 | 2.55 | 2.71 | 1,758,828 | |
| 10/14/2024 | 2.63 | 2.66 | 2.58 | 2.63 | 1,307,540 | |
| 10/11/2024 | 2.60 | 2.65 | 2.54 | 2.65 | 1,494,343 | |
| 10/10/2024 | 2.63 | 2.63 | 2.56 | 2.62 | 1,134,259 | |
| 10/09/2024 | 2.74 | 2.78 | 2.63 | 2.64 | 1,459,920 | |
| 10/08/2024 | 2.58 | 2.75 | 2.56 | 2.74 | 1,338,725 | |
| 10/07/2024 | 2.72 | 2.74 | 2.58 | 2.58 | 1,110,808 | |
| 10/04/2024 | 2.64 | 2.75 | 2.64 | 2.70 | 1,383,041 | |
| 10/03/2024 | 2.48 | 2.64 | 2.41 | 2.61 | 2,648,922 | |
| 10/02/2024 | 2.66 | 2.66 | 2.50 | 2.53 | 2,352,975 | |
| 10/01/2024 | 2.76 | 2.81 | 2.55 | 2.67 | 3,119,030 | |
| 09/30/2024 | 2.85 | 3.01 | 2.74 | 2.80 | 1,202,692 | |
| 09/27/2024 | 2.78 | 2.91 | 2.76 | 2.91 | 1,162,606 | |
| 09/26/2024 | 2.66 | 2.74 | 2.62 | 2.72 | 934,292 | |
| 09/25/2024 | 2.67 | 2.69 | 2.57 | 2.62 | 1,758,957 | |
| 09/24/2024 | 2.69 | 2.74 | 2.62 | 2.67 | 1,168,877 | |
| 09/23/2024 | 2.83 | 2.86 | 2.64 | 2.67 | 2,005,164 | |
| 09/20/2024 | 2.86 | 2.94 | 2.80 | 2.80 | 5,038,024 | |
| 09/19/2024 | 3.02 | 3.07 | 2.86 | 2.91 | 4,744,328 | |
| 09/18/2024 | 2.91 | 3.03 | 2.78 | 2.88 | 2,269,705 | |
| 09/17/2024 | 2.78 | 2.90 | 2.64 | 2.88 | 2,816,918 | |
| 09/16/2024 | 2.97 | 2.97 | 2.71 | 2.76 | 1,160,205 | |
| 09/13/2024 | 2.69 | 2.98 | 2.69 | 2.96 | 1,980,776 | |
| 09/12/2024 | 2.90 | 2.97 | 2.64 | 2.66 | 2,216,320 | |
| 09/11/2024 | 2.80 | 2.93 | 2.67 | 2.91 | 3,673,522 | |
| 09/10/2024 | 2.48 | 2.84 | 2.46 | 2.83 | 1,545,017 | |
| 09/09/2024 | 2.41 | 2.52 | 2.39 | 2.48 | 1,337,384 | |
| 09/06/2024 | 2.51 | 2.57 | 2.37 | 2.41 | 1,096,103 | |
| 09/05/2024 | 2.58 | 2.64 | 2.49 | 2.51 | 1,085,491 | |
| 09/04/2024 | 2.49 | 2.59 | 2.47 | 2.58 | 1,175,038 | |
| 09/03/2024 | 2.58 | 2.71 | 2.48 | 2.51 | 1,842,588 |
About Allogene Therapeutics Stock history
Allogene Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Allogene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Allogene Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Allogene Therapeutics stock prices may prove useful in developing a viable investing in Allogene Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 156.9 M | 125.7 M | |
| Net Loss | -299.4 M | -314.3 M |
Allogene Therapeutics Quarterly Net Working Capital |
|
Allogene Therapeutics Stock Technical Analysis
Allogene Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Allogene Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Allogene Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Allogene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Allogene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (0.89) | |||
| Treynor Ratio | (0.03) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allogene Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Allogene Stock, please use our How to Invest in Allogene Therapeutics guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allogene Therapeutics. If investors know Allogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allogene Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.60) | Quarterly Revenue Growth (0.27) | Return On Assets (0.26) | Return On Equity (0.54) |
The market value of Allogene Therapeutics is measured differently than its book value, which is the value of Allogene that is recorded on the company's balance sheet. Investors also form their own opinion of Allogene Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Allogene Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allogene Therapeutics' market value can be influenced by many factors that don't directly affect Allogene Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Allogene Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Allogene Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allogene Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.